Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience.
Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience. Expert Opin Biol Ther. 2020 01; 20(1):95-104.
View in:
PubMed
subject areas
Adult
Aged
Dermatologic Agents
Female
Humans
Male
Middle Aged
Psoriasis
Severity of Illness Index
Treatment Outcome
Ustekinumab
authors with profiles
Mark Talamonti